IIM
CABA icon

INTECH Investment Management’s Cabaletta Bio CABA Stock Holding History

INTECH Investment Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31,148
Closed -$43.1K – 2485
2025
Q1 		$43.1K Buy
31,148
+10,945
+54% +$23.3K ﹤0.01% 2446
2024
Q4 		$45.9K Buy
20,203
+5,999
+42% +$21.1K ﹤0.01% 2337
2024
Q3 		$67K Buy
+14,204
New +$82.2K ﹤0.01% 1953

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

INTECH Investment Management's CABA Position: Q2 2025 in Review

INTECH Investment Management sold out of Cabaletta Bio (CABA) in Q2 2025, closing a stake of 31,148 shares — an estimated $43.1K sold.

INTECH Investment Management first reported a position in CABA in Q3 2024 and held it in 3 quarters. The position peaked at $67K in Q3 2024. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2025.

  • INTECH Investment Management reported no remaining Cabaletta Bio position as of Q2 2025 after selling out during the quarter.
  • INTECH Investment Management sold 31,148 Cabaletta Bio shares in Q2 2025, an estimated $43.1K.
  • INTECH Investment Management first reported a position in Cabaletta Bio in Q3 2024 and held it in 3 quarters.
  • INTECH Investment Management's Cabaletta Bio position peaked at $67K in Q3 2024.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2025.

Based on INTECH Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.